Recent studies have shown that the abnormal expression of genes in the PLIN family may be a potential prognostic biomarker for various types of cancer, including sarcoma, hepatocellular carcinoma, renal carcinoma and breast cancer (19–22). The gene discussed is PLIN1; the disease is hepatocellular carcinoma.